Odagiri E, Demura R, Demura H, Suda T, Ishiwatari N, Abe Y, Jibiki K, Shizume K
Radioassay Center, Tokyo Women's Medical College, Japan.
Endocrinol Jpn. 1988 Dec;35(6):795-802. doi: 10.1507/endocrj1954.35.795.
We studied the suppressibility of cortisol secretion in 15 patients with Cushing's disease by measuring morning plasma cortisol level as well as the 24-hour urinary free corisol (UFC) excretion following single doses of increasing amounts of dexamethasone (ranging from 0.5 to 32 mg) given at 11 p.m. The mean plasma cortisol level in patients with Cushing's disease was twice as high as in normal subjects, whereas the mean UFC in these patients was 6 times as high. Plasma cortisol in seven patients were suppressed by less than 4 mg of dexamethasone (in 2 cases, less than 0.5 mg; in 3 cases, less than 2 mg; and in 2 cases less than 4 mg). In these cases, basal plasma cortisol and UFC were less than 25 micrograms/dl and 350 micrograms/day, respectively. Among the other eight patients, plasma cortisol was partially suppressed in 5 cases and not suppressed in 3 cases by high doses of dexamethasone (16-32 mg). In these cases the basal plasma cortisol and UFC were more than 25 micrograms/dl and 350 micrograms/day, respectively. There was a significant correlation between the basal plasma cortisol and UFC (r = 0.687, p less than 0.01). These data suggest that the suppression by increasing amounts of dexamethasone in most cases with Cushing's disease was related to the severity of hypercortisolism.
我们通过测量早晨血浆皮质醇水平以及在晚上11点给予递增剂量(范围从0.5至32毫克)地塞米松单次给药后的24小时尿游离皮质醇(UFC)排泄量,研究了15例库欣病患者皮质醇分泌的可抑制性。库欣病患者的平均血浆皮质醇水平是正常受试者的两倍,而这些患者的平均UFC则是正常受试者的6倍。7例患者的血浆皮质醇被小于4毫克地塞米松抑制(2例中小于0.5毫克;3例中小于2毫克;2例中小于4毫克)。在这些病例中,基础血浆皮质醇和UFC分别小于25微克/分升和350微克/天。在其他8例患者中,高剂量地塞米松(16 - 32毫克)使5例患者的血浆皮质醇部分被抑制,3例未被抑制。在这些病例中,基础血浆皮质醇和UFC分别大于25微克/分升和350微克/天。基础血浆皮质醇和UFC之间存在显著相关性(r = 0.687,p小于0.01)。这些数据表明,在大多数库欣病病例中,递增剂量地塞米松的抑制作用与皮质醇增多症的严重程度相关。